The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Progesterone and estrogen receptors in meningiomas: prognostic considerations
Abstract
✓ Meningiomas often contain steroid hormone receptors, but the correlation of receptor presence with patient outcome or mitotic index is unclear. Intracranial meningiomas from 70 patients (27 males and 43 females, mean age 52.9 + 1.7 years [mean ± standard error of the mean], range 15–78 years) were evaluated immunocytochemically for female sex hormone receptors using specific monoclonal antibodies. Prognostic correlations were determined using statistical analyses that included clinical and histological variables. Twenty-eight tumors were benign, 27 had atypical features, and 15 were malignant. Thirty tumors were meningotheliomatous, 11 were fibroblastic, 28 were transitional, and one was secretory. Twenty-nine of the 70 primary tumors recurred (mean interval to recurrence 50.1 ± 10 months). The mean progression-free follow-up period for patients without recurrence was 82.1 ± 7.7 months. Nuclear staining for the progesterone receptor (PR) was found in 58 cases (83%) and PR status was scored as 0 (0% nuclei positive), 1 (< 1%), 2 (1–9%), 3 (10–49%), or 4 (> 50%). Only six tumors (8.6%) contained nuclear estrogen receptor (ER) staining, which was limited to a small number of nuclei (< 1%). Fisher's exact test (two-tailed) showed an inverse correlation between tumor grade and PR staining score (p ≤ 0.001), with 96% of benign and 40% of malignant meningiomas containing PR-positive nuclei. No correlation between age or histological subtype and PR score was detected. Meningiomas from female patients had more PRs (p ≤ 0.05). Analysis of variance revealed that the mitotic index (total counts of mitoses per 10 high-power fields) for tumors with 0 PR staining (18 ± 4.4) was higher (p ± 0.0001) than for those with PR scores of 1 to 4 (4.3 ± 1.9, 5.1 ± 2, 2.2 ± 0.8, and 1.7 ± 0.9, respectively). Univariate analysis indicated that the absence of PR, high mitotic index, and higher tumor grade were significant factors for shorter disease-free intervals. Multivariate analysis showed that a three-factor interaction model, with a PR score of 0, mitotic index greater than 6, and malignant tumor grade, was a highly significant predictor (p ≤ 0.0001) for worse outcome in patients harboring meningiomas. These data indicate that the presence of PRs, even in a small number of tumor cells, is a favorable prognostic factor for meningiomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathology of Tumours of the Nervous System
(1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199001000-00011 · Cited by 3,472
Meningioma: analysis of recurrence and progression following neurosurgical resection
Mirimanoff, R. O., Dosoretz, D. E., Linggood, R. M., Ojemann, R. G., & Martuza, R. L. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.62.1.0018 · Cited by 1,064
Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcome
Jääskeläinen, J., Haltia, M., & Servo, A. (1986) · Surgical Neurology · doi:10.1016/0090-3019(86)90233-8 · Cited by 475
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
Grunberg, S. M., Weiss, M. H., Spitz, I. M., Ahmadi, J., Sadun, A., Russell, C. A., Lucci, L., & Stevenson, L. L. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.6.0861 · Cited by 379
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance
Maier, H., Öfner, D., Hittmair, A., Kitz, K., & Budka, H. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.4.0616 · Cited by 283
Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*
PRESS, M. F., & GREENE, G. L. (1988) · Endocrinology · doi:10.1210/endo-122-3-1165 · Cited by 230
Estrogen-receptor protein in intracranial meningiomas
Donnell, M. S., Meyer, G. A., & Donegan, W. L. (1979) · Journal of Neurosurgery · doi:10.3171/jns.1979.50.4.0499 · Cited by 222
Relationship of presence of progesterone receptors to prognosis in early breast cancer.
Pichon, M.-F., Pallud, C., Brunet, M., & Milgröm, E. (1980) · PubMed · Cited by 164
Hormonal manipulation of meningiomas in vitro
Olson, J. J., Beck, D. W., Schlechte, J., et al. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.1.0099 · Cited by 143
Saati, T. A., Cohen‐Knafo, E., Caveriviere, P., Delsol, G., Clamens, S., Faye, J. C., Prats, H., Bayard, F., Coindre, J., & Wafflart, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550423 · Cited by 143
Antiprogestins, a new form of endocrine therapy for human breast cancer.
Klijn, J. G. M., Jong, F. H. D., Bakker, G. H., Lamberts, S. W. J., Rodenburg, C. J., & Alexieva-Figusch, J. (1989) · PubMed · Cited by 141
Michelsen, J. J., & New, P. F. J. (1969) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.32.4.305 · Cited by 124
Modulation of meningioma cell growth by sex steroid hormones in vitro
Jay, J. R., MacLaughlin, D. T., Riley, K. R., & Martuza, R. L. (1985) · Journal of neurosurgery · doi:10.3171/jns.1985.62.5.0757 · Cited by 117
INTRACRANIAL MENINGIOMA-A POPULATION STUDY OF TEN YEARS
Rausing, A., Ybo, W., & Stenflo, J. (1970) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb05608.x · Cited by 115
Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice
Olson, J. J., Beck, D. W., Schlechte, J., et al. (1987) · Journal of neurosurgery · doi:10.3171/jns.1987.66.4.0584 · Cited by 112
Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo
Matsuda, Y., Kawamoto, K., Kiya, K., et al. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.3.0527 · Cited by 85
Expression of androgen and progesterone receptors in primary human meningiomas
Maxwell, M., Galanopoulos, T., Neville-Golden, J., & Antoniades, H. N. (1993) · Journal of neurosurgery · doi:10.3171/jns.1993.78.3.0456 · Cited by 79
Adams, E. F., Schrell, U. M. H., Fahlbusch, R., & Thierauf, P. (1990) · Journal of neurosurgery · doi:10.3171/jns.1990.73.5.0750 · Cited by 78
Androgen receptor expression in meningiomas
Carroll, R. S., Zhang, J., Dashner, K., Sar, M., Wilson, E. M., & Black, P. M. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.3.0453 · Cited by 71
Immunocytochemical study of progesterone receptor in human meningioma
Perrot‐Applanat, M., Picard‐Groyer, M., & Kujas, M. (1992) · Acta Neurochirurgica · doi:10.1007/bf01400586 · Cited by 63
Miller, R. E. (1986) · Journal of Surgical Oncology · doi:10.1002/jso.2930310309 · Cited by 28
Expression of the c-erbB-2-encoded oncoprotein and progesterone receptor in human meningiomas
Schlegel, J., Ullrich, B., Stumm, G., Gass, P., Harwerth, I. M., Hynes, N., & Kiessling, M. (1993) · Acta Neuropathologica · doi:10.1007/bf00228582 · Cited by 26
Cited by
Epidemiology and etiology of meningioma
Wiemels, J., Wrensch, M., & Claus, E. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0386-3 · Cited by 1,226
Histological classification and molecular genetics of meningiomas
Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70625-1 · Cited by 573
Whittle, I. R., Smith, C., Navoo, P., & Collie, D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16153-9 · Cited by 564
Progesterone production and actions in the human central nervous system and neurogenic tumors
Inoue, T., Akahira, J.-I., Suzuki, T., Darnel, A. D., Kaneko, C., Takahashi, K., Hatori, M., Shirane, R., Kumabe, T., Kurokawa, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012096 · Cited by 96
Estrogen and progesterone therapy and meningiomas
Hage, M., Plesa, O., Lemaire, I., & Raffin Sanson, M. L. (2022) · Endocrinology · doi:10.1210/endocr/bqab259 · Cited by 63
Metadata
- Authors
- Hsu, D. W., Efird, J. T., & Hedley-Whyte, E. T.
- Venue
- Journal of Neurosurgery
- Published
- 1997-01
- Volume
- 86
- Issue
- 1
- Pages
- 113-120
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2015176155
- Cited by
- 359
- References
- 23
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.